Menopause & the
Metabolic Shift.
Weight, blood sugar and blood pressure all seem to shift at once around menopause, as if a switch had been thrown. The truer picture is gentler and more useful: for decades a quietly protective hormone was buffering a metabolic tendency the modern diet had been building underneath. Menopause doesn't light the fire. It removes the blanket.
Nothing new is added. Something helpful is taken away.
It is tempting to picture menopause as flipping a metabolic switch to the "bad" position. The truer account: oestrogen was quietly buffering a metabolic tendency for years, and menopause removes the buffer rather than creating a new problem. That reframing explains both why the change can feel sudden — the buffer lifts all at once — and why it is not the same for every woman.
Oestradiol, acting largely through oestrogen receptor alpha, supports insulin sensitivity in muscle, liver and fat, supports the pancreas's beta cells, tends to be anti-inflammatory, and keeps the lipid profile favourable.[1] None of this is dramatic day to day — which is exactly why it goes unnoticed. It is a background buffer. When oestradiol falls at menopause, the buffer lifts all at once: insulin sensitivity drops, the beta cells lose some support, and the lipids drift the wrong way (LDL and triglycerides up, HDL down).
Drag the oestrogen level down, from the premenopausal years toward menopause, and watch four markers drift out of the protective zone together — because one hormone was holding all four. This is the buffer being removed, made visible.
The four don't drift independently. One hormone was holding all of them in the protective zone, so when it withdraws they move together — which is why the change can feel like a single event rather than four separate ones.
Fat moves to the dangerous depot.
The largest contributor is where fat is stored. Before menopause, oestrogen steers fat to the subcutaneous, hip-and-thigh depot — the "pear" pattern, metabolically benign and arguably protective. As oestrogen falls, fat redistributes to the visceral, abdominal depot — the "apple" pattern.[2]
This matters because visceral fat is the metabolically dangerous kind: inflammatory, lipolytically active, and directly insulin-resistance-driving. And it is exactly where this chapter meets the cholesterol–steroid road: cortisol also preferentially lays down visceral fat, so the two effects load the same depot. In a woman whose sleep is being wrecked by hot flushes, cortisol from the disrupted sleep feeds the same abdominal store, on top of the oestrogen-driven redistribution.
Insulin, SHBG, and a mirror of PCOS.
As oestrogen falls, so does sex hormone-binding globulin (SHBG), the carrier that keeps sex hormones bound and quiet — unmasking a larger free fraction of the remaining androgens. Low SHBG is both a marker of and a participant in insulin resistance, and insulin itself lowers SHBG.[3] So a self-reinforcing loop forms: falling oestrogen lowers SHBG, rising insulin lowers it further, more free androgen tracks with more central fat, which drives more insulin resistance.
Where cortisol fits — and the ageing confounder.
Cortisol is a genuine contributor, but a secondary one, acting mostly through sleep disruption: hot flushes wreck sleep, disrupted sleep raises cortisol, and cortisol opposes insulin and loads visceral fat. Real — but a supporting actor, not the lead.
The second complication is honest and important: much of what looks like a "menopausal" metabolic decline is really midlife running alongside it. Muscle mass starts to fall, activity often drops, and muscle is the body's main glucose sink — so losing it reduces glucose disposal regardless of hormones. Disentangling the menopause-specific effect from plain ageing is genuinely hard. The good longitudinal work went looking for exactly this, and did find a menopause-specific component to the visceral-fat gain and lipid changes, beyond ageing alone.[2] So it is both, intertwined — the honest answer, not a tidy single cause.
It unmasks a tendency, rather than creating disease.
Not every woman develops metabolic trouble at menopause — which is the key to the whole picture. The transition tends to unmask or accelerate an underlying tendency rather than create disease from nothing. A woman entering it lean, active and muscular, eating in a way that keeps insulin low, may pass through with little metabolic disturbance; the transition reveals a vulnerability that was being held in check.
- Protect and build muscle — resistance training and adequate protein directly counter the muscle loss that erodes glucose disposal. The largest, most under-used metabolic lever at midlife.
- Lower the insulin load — because insulin is wired into SHBG, the androgen balance and visceral fat, reducing refined carbohydrate reaches several threads at once. The strongest single lever.
- Protect sleep — the route through which the cortisol contribution runs; easing the sleep disruption eases that thread.
Not a sentence. A buffer removed.
The midlife metabolic shift is real, common, and too often waved away as "just getting older" or "just menopause." The truer account is more useful: oestrogen was quietly buffering a metabolic tendency; its withdrawal removes the buffer; fat moves to the depot that drives insulin resistance; and insulin, SHBG and the androgen balance form a self-reinforcing loop — all tangled with the ordinary muscle loss of midlife.
Ask your body what the buffer was doing — and tend the terrain it leaves behind.
One entry point among the many of the one fire. Back to the whole: The Invisible Fire.
The blanket, not the fire.
Menopause is not a metabolic sentence, and it is not a switch thrown to the "bad" position. It is a buffer removed — a quietly protective hormone withdrawing after decades of holding a tendency in check. Which is precisely why the terrain underneath is the thing to tend, sooner rather than later: the levers that reach it are the same ones the whole series keeps arriving at.
Not a switch thrown, but a buffer removed — which is why the terrain underneath is the thing to tend.
[1] Mauvais-Jarvis F, Clegg DJ, Hevener AL (2013). The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34(3):309-338. PMID 23460719. Read →
[2] Greendale GA et al. (2019). Changes in body composition and weight during the menopause transition (SWAN). JCI Insight 4(5):e124865. PMID 30843880. Read →
[3] Wallace IR, McKinley MC, Bell PM, Hunter SJ (2013). Sex hormone binding globulin and insulin resistance. Clin Endocrinol (Oxf) 78(3):321-329. PMID 23121642. Read →
[4] Salpeter SR et al. (2006). Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome. Diabetes Obes Metab 8(5):538-554. PMID 16918589. (Estradiol partly reverses the shift — evidence of causation.) Read →
[5] Lee AA, Den Hartigh LJ (2025). Metabolic impact of endogenously produced estrogens by adipose tissue across the lifespan. Front Endocrinol 16:1682231. PMID 41180177. Read →